End TB Strategy top 10 indicators: current status in participant countries
|
|
- Harold Osborne
- 6 years ago
- Views:
Transcription
1 End TB Strategy top 10 indicators: current status in participant countries Dennis FALZON Global TB Programme, WHO/HQ Geneva Regional WHO / Global Fund meeting Kenya 20 September 2016
2 Objectives of the presentation 1. Summarize the main findings of the country survey of 5 of the top 10 indicators 2. Identify the main challenges in the generation of the indicators 3. Propose a framework to prioritize countryand indicator-specific solutions for investment
3 End TB Strategy top 10 indicators 1. TREATMENT COVERAGE 2. TREATMENT SUCCESS RATE 3. HOUSEHOLDS WITH CATASTROPHIC COSTS DUE TO TB 4. TB PATIENTS TESTED WITH A WRD AT DIAGNOSIS 5. LTBI TREATMENT COVERAGE 6. CONTACT INVESTIGATION COVERAGE 7. DST COVERAGE FOR TB PATIENTS 8. TREATMENT COVERAGE, NEW TB DRUGS 9. DOCUMENTATION OF HIV STATUS AMONG TB PATIENTS 10. CASE FATALITY RATIO
4 1. TREATMENT COVERAGE All TB MDR/RR-TB Source:
5 2. TREATMENT SUCCESS RATIO All TB (new & relapse, 2014) MDR/RR-TB, 2013 Source:
6 9. DOCUMENTATION OF HIV STATUS AMONG TB PATIENTS Source: WHO Global tuberculosis report 2015 (WHO/HTM/TB/ )
7 10. CASE FATALITY RATIO Source: WHO Global tuberculosis report 2015 (WHO/HTM/TB/ )
8 SUMMARY OF SURVEY REPLIES FOR NEW INDICATORS
9 4. TB PATIENTS TESTED WITH A WRD AT DIAGNOSIS % new & relapse cases diagnosed with a WRD Country BMU register compatible? Registers provide: Numerator Denominator Benin YES???? Ethiopia YES YES YES?? Kenya YES YES YES YES Malawi YES YES YES?? Mozambique YES YES YES?? Nigeria YES???? South Africa YES YES YES?? Swaziland YES YES YES?? Uganda YES YES YES?? Indicator generated? UR Tanzania YES NO NO Relapses reported under retreatment ; need to go to Rx card and lab register Zimbabwe YES YES YES??
10 5. LTBI TREATMENT COVERAGE % eligible household contacts <5 years started on LTBI treatment Country Data sources Numerator Denominator Aggregated data at national level? Benin Rx card of index c. & IPT register YES YES Yes (indicator generated quarterly ) Ethiopia TB register YES YES No Kenya TB register, others YES NO Yes Malawi TB register, others YES YES Yes Mozambique Contact register YES YES Yes Nigeria Special register YES YES Yes (<6y contact of bact+) South Africa Rx card of index c. YES NO No Swaziland Uganda Soon new contact & IPT registers TB, IPT & contact registers, er&r - - No YES YES Yes & No (? Developing) UR Tanzania Not captured - - No Zimbabwe contact & IPT registers; DHIS2 YES YES Yes
11 6. CONTACT INVESTIGATION COVERAGE % eligible contacts of bact.-confirmed TB evaluated for TB Country Data sources Registers provide: Indicator generated? Numerator Denominator Benin Not captured - - NO; no national guidance Ethiopia TB register YES YES NO Kenya TB register (low completeness) - -?more data from partners Malawi TB & contact registers YES YES YES; use special DCF Mozambique Contact register YES YES YES Nigeria New register & report YES YES NO (to start soon) South Africa Rx card of index SOME NO NO Swaziland Not captured - - New registers soon Uganda Not captured - - UR Tanzania Not captured - - NO Zimbabwe TB register YES YES NO
12 7. DST COVERAGE FOR TB PATIENTS % TB cases with DST results for at least rifampicin Country BMU register compatible? Registers provide: Numerator Denominator Benin YES?YES?YES?? Ethiopia???????? Kenya YES YES YES?? Indicator being generated? Malawi YES YES YES YES; use special logbook Mozambique YES YES YES? possibly Nigeria YES YES YES? South Africa YES YES YES?? Swaziland YES YES YES?? Uganda YES YES YES YES UR Tanzania YES?YES?YES?? Zimbabwe YES YES YES YES; DHIS2 at facility level
13 Country 8. TREATMENT COVERAGE, NEW TB DRUGS % eligible TB cases on bedaquiline or delamanid New TB drugs available? Data on R&R system? Data sources Eligibility recorded? Benin YES YES List of RR-TB/pre-/XDR cases? Ethiopia YES NO - - Kenya YES YES Rx logbook; facility and electronic register s Malawi NO - Will be updated if new drugs introduced Mozambique NO - - NO Nigeria NO - Expected in 2017? South Africa YES YES Electronic register YES Swaziland YES YES DR-TB register; new tools YES Uganda YES YES DR TB unit Register and NTRL DST reports UR Tanzania YES NO RR-TB list; SLD Rx card YES Zimbabwe NO NO To be updated as new drugs? YES - YES
14 INDICATORS BEING DERIVED ALREADY? Country 4 WRD 5 LTBI Rx 6 Contact 7 DST 8 New Rx Benin?????? Ethiopia???? Kenya???? Malawi?? No Bdq Mozambique???? No Bdq Nigeria???? No Bdq South Africa?????? Swaziland?????? Uganda???? UR Tanzania?? Zimbabwe?? No Bdq
15 Conceptual framework to focus on the main challenges Score the relative challenges to derive each indicator in your country (least 1-> most 6) Data source (e.g. accessing data from laboratories or from inexistent vital registration systems) Disaggregation (e.g. data available but not collected in a manner which permits certain aggregations/summarization) Data management (e.g. inefficiencies of paper-based registers; no automated dashboards to summarize the indicators) Definitional (e.g. user understanding of what is a contact, how to define a cure or validity of drug resistance results data) Indicators Resources (e.g. lack of staff devoted to M & E; no investment in electronic surveillance) 2 3 Other (please specify ) - - example
16 -> Roadmap Critical actions and technical assistance needs to implement the Top 10 indicators of the End TB strategy - Revising national M&E plan - Human resources including manpower, training - Supervision/data audit and feedback - Revise recording and reporting system (e.g. er&r) - Integrate indicators into national health information system
Monitoring top 10 indicators. Philippe Glaziou September 2016
Monitoring top 10 indicators Philippe Glaziou September 2016 Global TB Report 2016 outline top-10 indicators 1. Introduction 2. The SDGs, End TB Strategy and a new era of global TB monitoring 3. TB disease
More informationCurrent status of implementation and monitoring and evaluation of collaborative TB/HIV activities. Avinash Kanchar
Current status of implementation and monitoring and evaluation of collaborative TB/HIV activities Avinash Kanchar Outline WHO guide to M&E of collaborative TB/HIV activities: 2015 Reporting status on Global
More informationInvesting for Impact
Global Fund Strategic Framework: Investing for Impact M&E: Capturing data to improve services Workshop to Scale Up the Implementation of Collaborative TB/HIV Activities in Africa 10-11 April, 2013; Maputo,
More informationUGANDA NATIONAL TUBERCULOSIS AND LEPROSY CONTROL PROGRAMME
MINISTRY OF HEALTH UGANDA TIOL TUBERCULOSIS AND LEPROSY CONTROL PROGRAMME Revised Strategic Plan 2015/16-2019/20 Monitoring and Evaluation Plan Narrative of the Operational, Budget and Technical Assistance
More informationDefinitions and reporting framework for tuberculosis 2013 revision. Dennis Falzon Global Forum of Xpert MTB/RIF Implementers Annecy 17 April 2013
Definitions and reporting framework for tuberculosis 2013 revision Dennis Falzon Global Forum of Xpert MTB/RIF Implementers Annecy 17 April 2013 2-year revision process WHO/HTM/TB/2013.2 2 www.who.int/iris/bitstream/10665/79199/1/9789241505345_eng.pdf
More informationSession-1: Template for country presentation (EXISTING Indicators)
Session-1: Template for country presentation (EXISTING Indicators) Instruction This presentation is expected to provide Country perspective on use of following Existing indicators among the top 10 indicators
More informationPrevention targets & scorecard
Prevention targets & scorecard Context Three opportunities For the first time: Global programmatic targets (UN Political Declaration 2016) Translate into pragmatic country road map targets Country and
More information511,000 (57% new cases) ~50,000 ~30,000
Latest global TB estimates - 2007 (Updated Mar 2009) All forms of TB Greatest number of cases in Asia; greatest rates per capita in Africa Multidrug-resistant TB (MDR-TB) Estimated number of cases 9.27
More informationAssessing the programmatic management of drug-resistant TB
Assessing the programmatic management of drug-resistant TB a. Review the programmatic management of drug-resistant TB patients with the TB manager. i. What is the size of MDR-TB problem locally? How many
More informationANALYSIS AND USE OF HEALTH FACILITY DATA. Guidance for tuberculosis programme managers
ANALYSIS AND USE OF HEALTH FACILITY DATA Guidance for tuberculosis programme managers WORKING DOCUMENT SEPTEMBER 2018 World Health Organization 2018 All rights reserved. This is a working document and
More informationUpdates on the global TB Global TB burden Policy response Treatment approaches
Ernesto Updates on the global TB Global TB burden Policy response Treatment approaches Ernesto Jaramillo WHO Global TB Programmme World Health Organization, Geneva, Tuberculosis is the leading infectious
More informationHealth Situation Room. Introduction to the Concept 2018
Health Situation Room Introduction to the Concept 2018 What is a Health Situation Room? Health Situation Room is an innovative data visualization platform, which allows decision makers and programme
More informationAssessment of the performance of TB surveillance in Kenya main findings, key recommendations and associated investment plan
Assessment of the performance of TB surveillance in Kenya main findings, key recommendations and associated investment plan Accra, Ghana May 1 st 2013 Hillary K. Kipruto on behalf of the Kenya team System
More informationHIV Drug Resistance Regional Update Eastern & Southern African Region
HIV Drug Resistance Regional Update Eastern & Southern African Region Dr R Banda, IST/ESA Dr F Cham, IST/ESA Dr RG Vaz, WHO AFRO HIVDR Steering Committee Meeting, Geneva 11-12 November 2009 1 Presentation
More informationWHO Task Force Framework on assessment of TB surveillance data - Revisiting the "Onion model" Ana Bierrenbach WHO consultant Nov/Dec 2010
WHO Task Force Framework on assessment of TB surveillance data - Revisiting the "Onion model" Ana Bierrenbach WHO consultant Nov/Dec 2010 Task Force on TB Impact Measurement Mandate To produce a robust,
More informationPROGRESS REPORT ON CHILD SURVIVAL: A STRATEGY FOR THE AFRICAN REGION. Information Document CONTENTS
29 June 2009 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Fifty-ninth session Kigali, Republic of Rwanda, 31 August 4 September 2009 Provisional agenda item 9.2 PROGRESS REPORT ON CHILD SURVIVAL: A
More informationHIV DIAGNOSTIC TESTS IN LOW- AND MIDDLE-INCOME COUNTRIES: FORECASTS OF GLOBAL DEMAND FOR
HIV DIAGNOSTIC TESTS IN LOW- AND MIDDLE-INCOME COUNTRIES: FORECASTS OF GLOBAL DEMAND FOR 2015 2020 Presented by Vincent Habiyambere (WHO), Biyi Adesina (Avenir Health) and Meghan Wareham (CHAI) on behalf
More informationMultidrug-Resistant TB
Multidrug-Resistant TB Diagnosis Treatment Linking Diagnosis and Treatment Charles L. Daley, M.D. National Jewish Health University of Colorado Denver Disclosures Chair, Data Monitoring Committee for delamanid
More informationInformation Note. WHO call for patient data on the treatment of multidrug- and rifampicin resistant tuberculosis
Information Note WHO call for patient data on the treatment of multidrug- and rifampicin resistant tuberculosis In order to ensure that the upcoming comprehensive revision of WHO policies on treatment
More informationChildhood TB and new TB drugs in the WHO European Region
Andrei Dadu Carl Cordonnier Maxim Dondiuk Childhood TB and new TB drugs in the WHO European Region Kigali, Rwanda, 09/10/ 2017 Dr Martin van den Boom, MD, MSc PH, WHO Regional Office for Europe, Joint
More informationCall to Action To Accelerate Access to DR-TB Drugs: 2016 Update
Call to Action To Accelerate Access to DR-TB Drugs: 2016 Update June 3, 2016 On March 10 th, 2015, Médecins Sans Frontières (MSF), ACTION Global Health Advocacy Partnership, SWIFT Response Project, Treatment
More informationBackground. events and processes leading up to this meeting
Background events and processes leading up to this meeting Where it began. In some countries, flour fortification started without any baseline information on vitamin and mineral deficiencies In some countries,
More informationUNAIDS 2013 AIDS by the numbers
UNAIDS 2013 AIDS by the numbers 33 % decrease in new HIV infections since 2001 29 % decrease in AIDS-related deaths (adults and children) since 2005 52 % decrease in new HIV infections in children since
More informationMinistry of Health. National Tuberculosis Control Program INTEGRATED TB HIV PROGRAM REPORT (JANUARY JUNE 2015)
Ministry of Health National Tuberculosis Control Program INTEGRATED TB HIV PROGRAM REPORT (JANUARY JUNE 2015) Contents Executive summary... 2 Background... 3 National Tuberculosis Program Overview... 3
More informationThe New WHO guidelines on intensified TB case finding and Isoniazid preventive therapy and operational considerations
Workshop to accelerate the implementation of the Three Is for HIV/TB and earlier initiation of ART in Southern Africa, March 14-18, 2011, Johannesburg, South Africa. The New WHO guidelines on intensified
More informationTechnical Review Meeting of Country Experiences in ARV Toxicity Surveillance: Sharing Results and Lessons Learnt, Identifying Solutions
Technical Review Meeting of Country Experiences in ARV Toxicity Surveillance: Sharing Results and Lessons Learnt, Identifying Solutions 7-8 November 2013, Geneva Excellent healthcare locally delivered
More informationLatest developments in WHO estimates of TB disease burden
Latest developments in WHO estimates of TB disease burden WHO Global Task Force on TB Impact Measurement meeting Glion, 1-4 May 2018 Philippe Glaziou, Katherine Floyd 1 Contents Introduction 3 1. Recommendations
More informationWHO Global Task Force on TB Impact Measurement An overview
WHO Global Task Force on TB Impact Measurement An overview Katherine Floyd (WHO/GTB/TME) 3 rd meeting of the TB estimates subgroup Glion-sur-Montreux, 31March 2 April 2015 GLOBAL TB PROGRAMME 1. Broad
More informationFAST-TRACK: HIV Prevention, treatment and care to End the AIDS epidemic in Lesotho by 2030
Evidence informed, responsive and sustainable care FAST-TRACK: HIV Prevention, treatment and care to End the AIDS epidemic in Lesotho by 2030 Alti Zwandor UNAIDS Country Director Maseru, Lesotho 9 December
More informationChristian Gunneberg MO WHO The 14th Core Group Meeting of the TB/HIV Working Group November 11-12, 2008, Addis Ababa, Ethiopia
The revised TB/HIV indicators and update on the process of harmonization Christian Gunneberg MO WHO The 14th Core Group Meeting of the TB/HIV Working Group November 11-12, 2008, Addis Ababa, Ethiopia Monitoring
More informationThe United Nations flag outside the Secretariat building of the United Nations, New York City, United States of America
The United Nations flag outside the Secretariat building of the United Nations, New York City, United States of America Mike Segar / Reuters Executive Summary Context On 26 September 2018, the United Nations
More informationAppendix 3 Sample size and cost of surveys
Appendix 3 Sample size and cost of surveys Here we estimate the sample sizes needed to carry out prevalence of infection and disease, incidence of disease and verbal autopsy surveys in the 22 high burden
More informationEnding the AIDS Epidemic in Adolescents
Ending the AIDS Epidemic in Adolescents Eastern and Southern Africa Regional Update on the ALL IN Overview 13 October 2015 AIDS-related deaths has declined for all age groups Except adolescents! Eastern
More informationWHO HIV Drug Resistance Prevention and Assessment Strategy. Dr Richard Banda Technical Officer, HIV Drug Resistance WHO Inter-country Support Team
WHO HIV Drug Resistance Prevention and Assessment Strategy Dr Richard Banda Technical Officer, HIV Drug Resistance WHO Inter-country Support Team Eastern & Southern African Countries (ESA) 2 The HIV epidemic
More informationASLM Building laboratory capacity in Africa in a sustainable way
ASLM Building laboratory capacity in Africa in a sustainable way Tsehaynesh Messele, PhD ASLM, Chief Executive Officer Annual AMDS meeting September 29-30, 2014 Geneva Laboratory capacity gaps in Africa
More informationTuberculosis in England 2018 report (presenting data to end of 2017) Tables and figures slide set
Tuberculosis in England 2018 report (presenting data to end of 2017) Tables and figures slide set Number of TB notifications and rates, England, 1971-2017 2 Tuberculosis in England: 2018 report, Office
More informationBalancing investment in point of care diagnostics versus laboratory testing in low resource settings. June 28, 2011
Balancing investment in point of care diagnostics versus laboratory testing in low resource settings Workshop on TB and HIV Diagnostics Workshop on TB and HIV Diagnostics June 28, 2011 Complexity Delivery
More informationOptimizing Quality of Life through Palliative Care for Adults and Children affected by Cancer
Optimizing Quality of Life through Palliative Care for Adults and Children affected by Cancer The Public Health need for Palliative Care for Adults and Children with Cancer Dr Emmanuel Luyirika 105M-T3
More informationTuberculosis prevention: An under prioritized YET critical intervention to reduce child tuberculosis morbidity and mortality
Tuberculosis prevention: An under prioritized YET critical intervention to reduce child tuberculosis morbidity and mortality Moorine Penninah Sekadde Childhood TB focal point, NTP Uganda Annual meeting
More informationChange In Population TB Incidence Trends After The Roll-Out Of ART in Karonga District, North Malawi:
Change In Population TB Incidence Trends After The Roll-Out Of ART in Karonga District, North Malawi: 1986-2009 Rein Houben/Sebastian Mboma Karonga Prevention Study Incidence of SS+ TB (n/100,000/year
More informationThe human immunodeficiency virus/acquired immune
Vol. 7(4), pp. 44-48, May 2015 DOI: 10.5897/JAHR2014.0320 Article Number: 70F676253212 ISSN 2141-2359 Copyright 2015 Author(s) retain the copyright of this article http://www.academicjournals.org/jahr
More informationDiagnostic Procurement The Clinton Foundation HIV/AIDS Initiative
Diagnostic Procurement The Clinton Foundation HIV/AIDS Initiative 28 October 2008 Geneva 1 CHAI Work in Diagnostics - Context Diagnostic Test Agreements - In 2002 when CHAI was formed, the price of many
More informationUSING MATHEMATICAL MODELING FOR POLICY AND STRATEGIC PLANNING A case study of VMMC Scale-Up in Eastern and Southern Africa
USING MATHEMATICAL MODELING FOR POLICY AND STRATEGIC PLANNING A case study of VMMC Scale-Up in Eastern and Southern Africa INTEREST 2018 Kigali, Rwanda Emmanuel Njeuhmeli, MD, MPH, MBA Senior Medical Advisor
More informationProgress in scaling up HIV prevention and treatment in sub-saharan Africa: 15 years, the state of AIDS
10 th International Workshop on HIV treatment, Pathogenesis and Prevention Research in Resource-Limited setting (INTEREST, 3-6 May, 2016) Progress in scaling up HIV prevention and treatment in sub-saharan
More informationStrengthening Lab Capacity for TB Diagnosis and Care in LMICs
Strengthening Lab Capacity for TB Diagnosis and Care in LMICs Raising the Bar June 20, 2018 Advanced TB Diagnostics Course McGill University, Montreal Kathleen England, PhD MSc TB Diagnostics Advisor MSF
More informationInvesting for Impact Prioritizing HIV Programs for GF Concept Notes. Lisa Nelson, WHO Iris Semini, UNAIDS
Investing for Impact Prioritizing HIV Programs for GF Concept Notes Lisa Nelson, WHO Iris Semini, UNAIDS Top 5 Lessons Learned 1 2 3 4 5 Prioritize within the allocation amount Separate above allocation
More informationThe epidemiology of tuberculosis
The epidemiology of tuberculosis Tuberculosis Workshop Shanghai, 12-22 May 28 Philippe Glaziou World Health Organization Outline Epidemiology refresher Estimates of tuberculosis disease burden Notifications
More informationAccelerating Children s HIV Treatment (ACT): Rationale, Progress & Challenges
Accelerating Children s HIV Treatment (ACT): Rationale, Progress & Challenges George Siberry, MD, MPH OGAC Senior Technical Advisor for Pediatrics March, 2016 Compared to Adults, Children (
More informationCertainty assessment of patients Effect Certainty Importance. a standardised 9 month shorter MDR-TB regimen. e f
Author(s): STREAM Stage 1 Trial investigators reported for the Guideline Development Group for the WHO treatment guidelines on MDR/RR-TB, 2018 update (6 July 2018) - FINAL RESULTS Question: PICO 1. In
More informationincreased efficiency. 27, 20
Table S1. Summary of the evidence on the determinants of costs and efficiency in economies of scale (n=40) a. ECONOMETRIC STUDIES (n=9) Antiretroviral therapy (n=2) Scale was found to explain 48.4% of
More informationRapid Diagnostics CHAI Experience. 6 th Moving Forward in Diagnostics Forum Les Pensieres November 7, 2012
Rapid Diagnostics CHAI Experience 6 th Moving Forward in Diagnostics Forum Les Pensieres November 7, 2012 CHAI is working in 12 countries on HIV POC test implementation Kenya Tanzania Ethiopia Malawi Mozambique
More informationGlobal TB control: Current status with particular attention to TB among women and children
Global TB control: Current status with particular attention to TB among women and children Katherine Floyd Stop TB Department World Health Organization 42 nd Union World Conference on Lung Health Stop
More information: uptake and impact of Xpert MTB/RIF
Photo: Riccardo Venturi 21-215: uptake and impact of Xpert MTB/RIF Wayne van Gemert WHO Global TB Programme, Geneva Joint Partners Forum for Strengthening and Aligning TB Diagnosis and Treatment 27-3 April
More informationAll [HIV-exposed] infants should receive oral antiretroviral prophylaxis for the entire duration of breastfeeding - CON
All [HIV-exposed] infants should receive oral antiretroviral prophylaxis for the entire duration of breastfeeding - CON Amy Slogrove Stellenbosch University 10 th International HIV Pediatrics Workshop
More informationPolicies for VMMC in 14 priority countries of east and southern Africa
Policies for VMMC in 14 priority countries of east and southern Africa Andre Verani, JD, MPH Senior Policy Analyst Division of Global HIV and TB Centers for Disease Control and Prevention, Atlanta, USA
More informationUpdate on the Global Use of Bedaquiline and Delamanid for Programmatic Management of Drug- Resistant Tuberculosis
Update on the Global Use of Bedaquiline and Delamanid for Programmatic Management of Drug- Resistant Tuberculosis DR-TB Scale-Up Treatment Action Team (DR-TB STAT) October 2017 Content What is DR-TB STAT?
More informationWhat is new in WHO-guidelines relevant for childhood TB?
Photo: Riccardo Venturi What is new in WHO-guidelines relevant for childhood TB? Dr Malgosia Grzemska Coordinator, Technical Support, Stop TB Department World Health Organization, Geneva, Switzerland 12th
More informationRepositioning AIDS: The World Bank s Approach to Improved Efficiency and Effectiveness Using HIV Program Science Principles
Repositioning AIDS: The World Bank s Approach to Improved Efficiency and Effectiveness Using HIV Program Science Principles Marelize Gorgens mgorgens@worldbank.org The World Bank s Global HIV/AIDS Program
More informationIndicators for MDR-TB detection and outcomes
Indicators for MDR-TB detection and outcomes Dennis FALZON TB surveillance and surveys: A training workshop for consultants Geneva, Switzerland - 26 May 2011 Reference 2 Aggregated forms pages 161 162
More informationTB Disease Prevalence Survey - Progress Report
TB Disease Prevalence Survey - Progress Report 30 Oct 2011, Lille Ikushi Onozaki MD, MPH Team Leader, TB Prevalence Survey WHO Global Task Force on TB Impact Measurement Stop TB Department, WHO onozakii@who.int
More informationPEPFAR Malawi Baobab Health Trust EMRS
PEPFAR Malawi Baobab Health Trust EMRS Leveraging Patient-level Systems for Surveillance & Monitoring September 13, 2017 Johannesburg, South Africa What is the Baobab EMRS System? Modular Point of care
More informationControlling TB in the era of HIV
Controlling TB in the era of HIV Christy Hanson, PhD, MPH TB Research Advisor Amy Bloom, MD TB/HIV Advisor TB Incidence rates highest in Africa Estimated new TB cases (all forms) per 100 000 population
More informationPolicy Brief. Pupil and Teacher Knowledge about HIV and AIDS in Zanzibar
Policy Brief N um b er 5 ( April 2011) Pupil and Teacher Knowledge about HIV and AIDS in Zanzibar www.sacmeq.org Introduction The HIV and AIDS pandemic presents a major challenge for the social and economic
More informationHIV Viral Load Testing Market Analysis. September 2012 Laboratory Services Team Clinton Health Access Initiative
HIV Viral Load Testing Market Analysis September 2012 Laboratory Services Team Clinton Health Access Initiative Agenda Background on Viral Load Testing Growth of Global Viral Load Market Factors Impacting
More informationGlobal Plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive
Global Plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive DR. Nicholas Muraguri OGW, MD,MPH, MBA, PhD (c) Director, Global Plan Secretariat www.zero-hiv.org
More informationProgress Report: Universal Access Target Setting in East and Southern Africa
Progress Report: Universal Access Target Setting in East and Report prepared by: Team for East & 15 September 2006 For all inquiries please contact Mark Stirling, Regional Director for Eastern and, at
More informationMalaria Funding. Richard W. Steketee MACEPA, PATH. April World Malaria Day 2010, Seattle WA
Malaria Funding Richard W. Steketee MACEPA, PATH April World Malaria Day 2010, Seattle WA Malaria Funding Is there a plan? Is there money? Where does the money come from? Is the money moving efficiently?
More informationCurrent and future HIV testing approaches and operational implications on testing uptake
Current and future HIV testing approaches and operational implications on testing uptake Dr Rachel Baggaley WHO MEETING WITH DIAGNOSTIC MANUFACTURERS AND STAKEHOLDERS GLOBAL FORECASTS OF DIAGNOSTIC DEMAND
More informationImpact Dashboard - October 2014
Impact Dashboard - 2014 By 2014, PSI and its network members averted an estimated 44.2 million DALYs globally. PSI has met 60.6% of the strategic plan (SP) target to avert 198.7 million DALYs, and 56.4%
More informationImpact Dashboard - August 2014
Impact Dashboard - By, PSI and its network members averted an estimated 29.7 million DALYs globally. PSI has met 53.3% of the strategic plan (SP) target to avert 198.7 million DALYs, and 53.0% of the SP
More informationPutting the recommendations into action
24 May, 2012 Putting the recommendations into action Dr Flavia BUSTREO Assistant Director General, Family, Women s and Children s Health Cluster on behalf of the multi-stakeholder implementation team The
More informationTB Disease Prevalence Survey - Overview, why and how
TB Disease Prevalence Survey - Overview, why and how Ikushi Onozaki MD, MPH Team Leader, TB Prevalence Survey WHO Global Task Force on TB Impact Measurement Stop TB Department, WHO onozakii@who.int 3 strategic
More informationAIDS in Africa. An Update. Basil Reekie
AIDS in Africa An Update Basil Reekie Contents General Statistics The trend of HIV in Africa Ugandan experience UNAIDS 2006 Latest African Statistics by Country HIV Intervention Light at the end of the
More informationWorld Health Organization 2013
World Health Organization 2013 All rights reserved. Publications of the World Health Organization are available on the WHO web site (www.who.int) or can be purchased from WHO Press, World Health Organization,
More informationElimination of mother to child transmission of HIV: is the end really in sight? Lisa L. Abuogi, MD University of Colorado, Denver Dec 3, 2014
Elimination of mother to child transmission of HIV: is the end really in sight? Lisa L. Abuogi, MD University of Colorado, Denver Dec 3, 2014 Outline Background History of prevention of mother to child
More informationBedaquiline and delamanid Experience of use in children. Bobojon Sharipov Deputy Director of the Republican Tuberculosis Control Centre
Tuberculosis in 2017: Searching for new solutions in the face of new challenges 6th TB Symposium Ministry of Health of the Republic of Belarus, Republican Scientific and Practical Center for Pulmonology
More informationPrinciples and Structure of a Research Protocol. Anthony D Harries The Union, Paris, France MSF, Brussels, Belgium
Principles and Structure of a Research Protocol Anthony D Harries The Union, Paris, France MSF, Brussels, Belgium BASIC STRUCTURE Background and rationale to study Aim and objectives (the research question)
More informationAccess to Stigma-Free Healthcare Settings for Key Populations: Challenges and Opportunities
#IAS2017 @IAS_conference Access to Stigma-Free Healthcare Settings for Key Populations: Challenges and Opportunities Dr. R. Cameron Wolf Senior HIV/AIDS Advisor for Key Populations U.S. Agency for International
More informationWorld Food Programme (WFP)
UNAIDS 2016 REPORT World Food Programme (WFP) Unified Budget Results and Accountability Framework (UBRAF) 2016-2021 2 Contents Achievements 2 Introduction 2 Innovative testing strategies 2 Access to treatment
More informationimpact dashboard - june 2018
impact dashboard - june 2018 As of June, PSI averted an estimated 11.3 M DALYs, provided 8.1 M CYPs, and reached 12.5 M users globally. Ethiopia, Zambia, and Cameroon have made considerable progress on
More informationAccess to reproductive health care global significance and conceptual challenges
08_XXX_MM1 Access to reproductive health care global significance and conceptual challenges Dr Lale Say World Health Organization Department of Reproductive Health and Research From Research to Practice:
More informationGuidance on Matching Funds: Tuberculosis Finding the Missing People with TB
February 2017 Guidance on Matching Funds: Tuberculosis Finding the Missing People with TB 1. Background TB is the leading cause of death by infectious disease, killing 1.8 million people in 2015. Each
More informationLatent TB Infection in the WHO European Region and recommendations on LTBI s M&E framework
Latent TB Infection in the WHO European Region and recommendations on LTBI s M&E framework 18 th Wolfheze workshops / 15 th NTP managers meeting, 31 May 02 June 2017 Dr Andrei DADU Technical officer, Joint
More informationimpact dashboard - may 2018
impact dashboard - may 2018 As of May, PSI averted an estimated 8.0 M DALYs, provided 6.2 M CYPs, and reached 8.1 M users globally. In May alone, PSI added 2.6 M users toward the goal of 90 M reached by
More informationMonitoring, Evaluation, and Reporting (MER) Guidance (v.2.3): TB and HIV
Monitoring, Evaluation, and Reporting (MER) Guidance (v.2.3): TB and HIV Sean Cavanaugh, Senior TB Technical Advisor Office of the U.S. Global AIDS Coordinator & Health Diplomacy August 2018 Video Outline
More informationExpert Group Meeting on Strategies for Creating Urban Youth Employment: Solutions for Urban Youth in Africa
Expert Group Meeting on Strategies for Creating Urban Youth Employment: Solutions for Urban Youth in Africa Measurement/indicators of youth employment Gora Mboup Global Urban Observatory (GUO) UN-HABITAT
More informationSOUTH AFRICA S TB BURDEN - OVERVIEW
SOUTH AFRICA S TB BURDEN - OVERVIEW Dr Aaron Motsoaledi, MP: Chairperson of the Board, Stop TB Partnership Minister of Health, South Africa 31 January 2014, Cape Town South Africa s TB Burden Global TB
More informationUpdate on Meningococcal A Vaccine Development and Introduction
Update on Meningococcal A Vaccine Development and Introduction WHO Product Development for Vaccines Advisory Committee Meeting (PD-VAC) @ Geneva, 7-9 September 2015 Dr Marie-Pierre Preziosi, WHO Initiative
More informationEPIDEMIOLOGY OF TUBERCULOSIS AND the IMPACT ON CHILDREN
EPIDEMIOLOGY OF TUBERCULOSIS AND the IMPACT ON CHILDREN Anneke C. Hesseling Professor in Paediatrics and Child Health Director: Desmond Tutu TB center Stellenbosch University 11 September 11 th International
More informationMDR, XDR and Untreatable Tuberculosis and Laboratory Perspectives. Martie van der Walt TUBERCULOSIS EPIDEMIOLOGY & INTERVENTION RESEARCH UNIT
TUBERCULOSIS EPIDEMIOLOGY & INTERVENTION RESEARCH UNIT MDR, XDR and Untreatable Tuberculosis and Laboratory Perspectives Martie van der Walt IOM Meeting 15-17 January 2013 introduction 1 min 150 words
More informationCopyright 2011 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved ISBN
UNAIDS DATA TABLES 2011 Copyright 2011 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved ISBN 978-92-9173-945-5 UNAIDS / JC2225E The designations employed and the presentation of
More informationElimination of New HIV Infections among Children by 2015 and Keeping their Mothers Alive:
Elimination of New HIV Infections among Children by 2015 and Keeping their Mothers Alive: Rationale for the call to action, progress to date and dealing with realities Rene Ekpini, MD, MPH Senior Adviser,
More informationDr Ade Fakoya Senior HIV Advisor
Strengthening community systems to support families, communities and health facilities to prevent parent-to-child transmission and improve the health of women and children Dr Ade Fakoya Senior HIV Advisor
More information4/25/2012. The information on patterns of infection and disease can assist in: Assessing current and evolving trends in TB
Sindy M. Paul, MD, MPH, FACPM May 1, 2012 The information on patterns of infection and disease can assist in: Assessing current and evolving trends in TB morbidity, including resistance Identifying people
More informationPROGRESS ON HEALTH-RELATED MILLENNIUM DEVELOPMENT GOALS AND THE POST 2015 HEALTH DEVELOPMENT AGENDA. Report of the Secretariat CONTENTS ANNEXES
26 November 2015 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Sixty-fifth session N Djamena, Republic of Chad, 23 27 November 2015 Agenda item 8 PROGRESS ON HEALTH-RELATED MILLENNIUM DEVELOPMENT GOALS
More informationHP+/Project SOAR Oral PrEP Modeling. Webinar Series: Five Ways to Accelerate Progress Toward the Goals January 16, 2018
HP+/Project SOAR Oral PrEP Modeling Webinar Series: Five Ways to Accelerate Progress Toward the 95-95-95 Goals January 16, 2018 Activity Overview 2 Activity Objective Provide impact, cost, and cost-effectiveness
More informationStart Free Stay Free AIDS Free progress report
Start Free Stay Free AIDS Free 217 progress report Copyright 217 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved. The designations employed and the presentation of the material
More informationIntroduction to the Family Planning Financing Roadmap
Introduction to the Family Planning Financing Roadmap ATTAINING SUSTAINABLE FINANCING FOR FAMILY PLANNING IN SUB-SAHARAN AFRICA ACCRA, JANUARY 2018 Catherine Barker Cantelmo 1 Website Purpose Create an
More informationIMMUNIZATION VACCINE DEVELOPMENT
IMMUNIZATION VACCINE DEVELOPMENT MONTHLY IMMUNIZATION AND POLIO UPDATE IN THE AFRICAN REGION January February 2017 (Vol 5 issue N 1) District data completeness and coverage of DTP3 containing vaccine per
More informationPolicy Brief. Pupil and Teacher Knowledge about HIV and AIDS in Mauritius
Policy Brief N um b er 5 ( M ay 2011) Pupil and Teacher Knowledge about HIV and AIDS in Mauritius www.sacmeq.org Introduction The HIV and AIDS pandemic presents a major challenge for the social and economic
More information